Trevi Therapeutics

195 Church Street 14th Floor New Haven, CT 06510
US
203-304-2499 Visit Website
Click to view Trevi Therapeutics's photo

Category

Life Sciences Employers

Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease.

Address

195 Church Street 14th Floor New Haven, CT 06510
US
View Larger Map
Get Directions

1WalletHub, 2024. 2U.S. Census Bureau, ACS 1Y, 2023. 3WalletHub, 2024. 4Milken Institute, 2022. 5Defined as per capita GDP; U.S. Bureau of Economic Analysis, 2023; U.S. Census Bureau, 2023; AdvanceCT calculations.

Demographic Information